| Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels BJ Bailus, SM Scheeler, J Simons, MA Sanchez, KT Tshilenge, ... Autophagy 17 (12), 4119-4140, 2021 | 33 | 2021 |
| Proteomic analysis of Huntington’s disease medium spiny neurons identifies alterations in lipid droplets KT Tshilenge, CG Aguirre, J Bons, AA Gerencser, N Basisty, S Song, ... Molecular & Cellular Proteomics 22 (5), 2023 | 9 | 2023 |
| N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties GK Scott, S Mahoney, M Scott, A Loureiro, A Lopez-Ramirez, JJ Tanner, ... Amino Acids 53 (12), 1927-1939, 2021 | 6 | 2021 |
| Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegeneration F Teramayi, J Bons, M Scott, GK Scott, A Loureiro, A Lopez-Ramirez, ... Brain Research 1826, 148733, 2024 | | 2024 |
| N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties (Jun, 10.1007/s00726-021-03012-9, 2021) GK Scott, S Mahoney, M Scott, A Loureiro, A Lopez-Ramirez, JJ Tanner, ... AMINO ACIDS 53 (12), 1941-1941, 2021 | | 2021 |
| N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties [Erratum: December 2021, v. 53 (12 … GK Scott, S Mahoney, M Scott, A Loureiro, A Lopez-Ramirez, JJ Tanner, ... | | 2021 |
